Viela Bio to be acquired for $3.1 billion

The move comes less than three years after the Gaithersburg biotech spun out of MedImmune.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.